Functional importance of L-and P/Q-type voltage-gated calcium channels in human renal vasculature

Hypertension

Volumn 58, Issue 3, 2011, Pages 464-470

  Hansen, Pernille B ^a   Poulsen, Christian B ^a   Walter, Steen ^b   Marcussen, Niels ^a   Cribbs, Leanne L ^c   Skøtt, Ole ^a   Jensen, Boye L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

calcium channel; Excitation contraction coupling; human; kidney; renal hemodynamics; vascular biology

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; MIBEFRADIL; NIFEDIPINE; OMEGA AGATOXIN IVA; POTASSIUM; VOLTAGE GATED CALCIUM CHANNEL;

ADULT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DEPOLARIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NEPHRECTOMY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RENAL ARTERY; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; VASOCONSTRICTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, Q-TYPE; CALCIUM CHANNELS, T-TYPE; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MIBEFRADIL; MICE; MICE, INBRED C57BL; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; OMEGA-AGATOXIN IVA; RENAL ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASOCONSTRICTION;

EID: 80051941605     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.170845     Document Type: Article

References (37)

1. Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A, Snutch TP, Tanabe T, Birnbaumer L, Tsien RW, Catterall WA. Nomenclature of voltage-gated calcium channels. Neuron. 2000;25: 533-535.
2. Andreasen D, Friis UG, Uhrenholt TR, Jensen BL, Skott O, Hansen PB. Coexpression of voltage-dependent calcium channels Cav1.2, 2.1a, and 2.1b in vascular myocytes. Hypertension. 2006;47:735-741. (Pubitemid 43740246)
3. Hansen PB, Jensen BL, Andreasen D, Skott O. Differential expression of T-and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res. 2001;89:630-638. (Pubitemid 32924218)
4. Hansen PB, Jensen BL, Andreasen D, Friis UG, Skott O. Vascular smooth muscle cells express the(1A) subunit of a P-/Q-type voltage-dependent Ca(2 )channel, and it is functionally important in renal afferent arterioles. Circ Res. 2000;87:896-902.
5. Mori Y, Friedrich T, Kim MS, Mikami A, Nakai J, Ruth P, Bosse E, Hofmann F, Flockerzi V, Furuichi T, Mikoshiba K, Imoto K, Tanabe T, Numa S. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature. 1991;350:398-402. (Pubitemid 21912234)
6. Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, Zamponi GW, Nargeot J, Snutch TP. Splicing of 1A subunit gene generates phenotypic variants of P-and Q-type calcium channels. Nat Neurosci. 1999;2:407-415. (Pubitemid 30491249)
7. Poulsen CB, Al-Mashhadi RH, Cribbs LL, Skott O, Hansen PB. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles. Kidney Int. 2011;79:443-451.
8. Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2 channel subtypes and pharmacology in the kidney. Circ Res. 2007;100: 342-353.
9. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536. (Pubitemid 26163714)
10. Loutzenhiser K, Loutzenhiser R. Angiotensin II-induced Ca(2 ) influx in renal afferent and efferent arterioles: differing roles of voltage-gated and store-operated Ca(2 ) entry. Circ Res. 2000;87:551-557.
11. Carmines PK, Fowler BC, Bell PD. Segmentally distinct effects of depolarization on intracellular [Ca2[ in renal arterioles. Am J Physiol. 1993;265:F677-F685.
12. Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Saruta T. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney. Hypertension. 2001;38: 343-347. (Pubitemid 34225663)
13. Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Takamatsu I, Ozawa Y, Saruta T. Divergent renal vasodilator action of Land T-type calcium antagonists in vivo. J Hypertens. 2001;19:2031-2037. (Pubitemid 33035808)
14. Yamamoto T, Hayashi K, Matsuda H, Kubota E, Tanaka H, Ogasawara Y, Nakamoto H, Suzuki H, Saruta T, Kajiya F. In vivo visualization of angiotensin II-and tubuloglomerular feedback-mediated renal vasoconstriction. Kidney Int. 2001;60:364-369. (Pubitemid 32587576)
15. Furukawa T, Nukada T, Miura R, Ooga K, Honda M, Watanabe S, Koganesawa S, Isshiki T. Differential blocking action of dihydropyridine Ca2 antagonists on a T-type Ca2 channel ( 1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol. 2005;45:241-246. (Pubitemid 40328146)
16. Ohishi M, Takagi T, Ito N, Terai M, Tatara Y, Hayashi N, Shiota A, Katsuya T, Rakugi H, Ogihara T. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) Study. Hypertens Res. 2007;30:797-806. (Pubitemid 47578241)
17. Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K. Protective effects of efonidipine, a T-and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb. 2009;16:568-575.
18. Ohta M, Sugawara S, Sato N, Kuriyama C, Hoshino C, Kikuchi A. Effects of benidipine, a long-acting T-type calcium channel blocker, on home blood pressure and renal function in patients with essential hypertension: a retrospective, 'real-world' comparison with amlodipine. Clin Drug Investig. 2009;29:739-746.
19. Brueggemann LI, Martin BL, Barakat J, Byron KL, Cribbs LL. Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking. Am J Physiol Heart Circ Physiol. 2005;288:H923-H935. (Pubitemid 40139681)
20. Sonkusare S, Palade PT, Marsh JD, Telemaque S, Pesic A, Rusch NJ. Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications. Vascul Pharmacol. 2006;44:131-142. (Pubitemid 43185988)
21. Zhang Z, Lin H, Cao C, Khurana S, Pallone TL. Voltage-gated divalent currents in descending vasa recta pericytes. Am J Physiol Renal Physiol. 2010;299:F862-F871.
22. Figueroa XF, Chen CC, Campbell KP, Damon DN, Day KH, Ramos S, Duling BR. Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? Am J Physiol Heart Circ Physiol. 2007;293:H1371-H1383. (Pubitemid 47367179)
23. Braunstein TH, Inoue R, Cribbs L, Oike M, Ito Y, Holstein-Rathlou NH, Jensen LJ. The role of L-and T-type calcium channels in local and remote calcium responses in rat mesenteric terminal arterioles. J Vasc Res. 2008;46:138-151.
24. Birnbaumer L, Campbell KP, Catterall WA, Harpold MM, Hofmann F, Horne WA, Mori Y, Schwartz A, Snutch TP, Tanabe T, Tsien RW. The naming of voltage-gated calcium channels. Neuron. 1994;13:505-506. (Pubitemid 24300158)
25. Salemme S, Rebolledo A, Speroni F, Petruccelli S, Milesi VL. P-/Q-and T-type Ca2 channels in smooth muscle cells from human umbilical artery. Cell Physiol Biochem. 2007;20:55-64. (Pubitemid 46956812)
26. Zamponi GW, Snutch TP. Modulation of voltage-dependent calcium channels by G proteins. Curr Opin Neurobiol. 1998;8:351-356. (Pubitemid 28288570)
27. Jun K, Piedras-Renteria ES, Smith SM, Wheeler DB, Lee SB, Lee TG, Chin H, Adams ME, Scheller RH, Tsien RW, Shin HS. Ablation of P/Q-type Ca(2 ) channel currents, altered synaptic transmission, and progressive ataxia in mice lacking the(1A)-subunit. Proc Natl Acad Sci USA. 1999;96:15245-15250. (Pubitemid 30019797)
28. Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calandriello L, Francia A, Spadaro M, Pierelli F, Salvi F, Ophoff RA, Frants RR, Frontali M. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet. 1997;6:1973-1978. (Pubitemid 27460375)
29. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the1A-voltage-dependent calcium channel. Nat Genet. 1997;15: 62-69.
30. Klugbauer N, Marais E, Lacinova L, Hofmann F. A T-type calcium channel from mouse brain. Pflugers Arch. 1999;437:710-715. (Pubitemid 29161927)
31. McDonough SI, Bean BP. Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons. Mol Pharmacol. 1998;54: 1080-1087. (Pubitemid 29002052)
32. Ball CJ, Wilson DP, Turner SP, Saint DA, Beltrame JF. Heterogeneity of L-and T-channels in the vasculature: rationale for the efficacy of combined L-and T-blockade. Hypertension. 2009;53:654-660.
33. Jensen LJ, Salomonsson M, Jensen BL, Holstein-Rathlou NH. Depolarization-induced calcium influx in rat mesenteric small arterioles is mediated exclusively via mibefradil-sensitive calcium channels. Br J Pharmacol. 2004;142:709-718. (Pubitemid 38969666)
34. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002;288:2981-2997.
35. Wenzel RR. Renal protection in hypertensive patients: selection of antihypertensive therapy drugs. Drugs. 2005;65:29-39. (Pubitemid 41480578)
36. Furukawa T, Nukada T, Namiki Y, Miyashita Y, Hatsuno K, Ueno Y, Yamakawa T, Isshiki T. Five different profiles of dihydropyridines in blocking T-type Ca(2 ) channel subtypes (Ca(v)3.1 (2(1G)), Ca(v)3.2 (2(1H)), and Ca(v)3.3 (2(1I))) expressed in Xenopus oocytes. Eur J Pharmacol. 2009;613:100-107.
37. Diochot S, Richard S, Baldy-Moulinier M, Nargeot J, Valmier J. Dihydropyridines, phenylalkylamines and benzothiazepines block N-, P/Qand R-type calcium currents. Pflugers Arch. 1995;431:10-19.